Trial Profile
A Phase I, Open-Label, Randomized Crossover Trial to Investigate the Pharmacokinetic Interaction Between Steady-State Lopinavir/Ritonavir and Single-Dose TMC207 in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Bedaquiline (Primary) ; Lopinavir/ritonavir
- Indications HIV infections; Tuberculosis
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 15 Jul 2009 Actual end date (1 May 2009) added as reported by ClinicalTrials.gov.
- 15 Jul 2009 Actual end date (1 May 2009) added as reported by ClinicalTrials.gov.
- 15 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.